Replies to post #267395 on Avid Bioservices Inc (CDMO)

[biopharm]

No one is placing any weight on the PII results.

The weight has already been placed on Phase II results and now the waiting period..... probably while the quiet period becomes more and more difficult.

NCCN, AstraZeneca, Memorial Sloan Kettering, Janssen, Pfizer, Bluebird Bio...... and a dozen more but we should probably wait a bit and allow everyone to realize that PS Targeting is not going under as predicted back in Sept of 2012

How many Millions does Peregrine have at this point?

$65 Million?

$60 Million?

... and no (Absolutely NO) debt ... and now AstraZeneca paying for much of the cost of trials.

Sunny skies ahead